Research111d agoDA Davidson Upgrades Lakeland Industries to Buy From Neutral, Lifts Price Target to $14 From $10$LAKE
Research111d agoCitigroup Downgrades Lionsgate Studios to Neutral From Buy, Adjusts Price Target to $12.60 From $11Lionsgate Studios (LION) has an average rating of overweight and mean price target of $11.68, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$LION
Research111d agoBarclays Downgrades Vale to Equalweight From Overweight, Adjusts Price Target to $17 From $16.50Vale (VALE) has an average rating of overweight and mean price target of $17.43, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$VALE
Research111d agoBarclays Upgrades Okta to Overweight From Equalweight, Price Target is $85Okta (OKTA) has an average rating of overweight and mean price target of $100.58, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$OKTA
Research111d agoBarclays Downgrades Janux Therapeutics to Underweight From Overweight, Adjusts Price Target to $14 From $29Janux Therapeutics (JANX) has an average rating of overweight and mean price target of $45.81, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$JANX
Research111d agoBarclays Downgrades Tvardi Therapeutics to Underweight From Equalweight, Adjusts Price Target to $3 From $4Tvardi Therapeutics (TVRD) has an average rating of overweight and mean price target of $8.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$TVRD
Research111d agoRaymond James Downgrades Schneider National to Market Perform From OutperformSchneider National (SNDR) has an average rating of overweight and mean price target of $28.71, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$SNDR
Research111d agoWells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35Centessa Pharmaceuticals ADR (CNTA) has an average rating of Hold and mean price target of $42.55, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$CNTA
Research111d agoGoldman Sachs Downgrades Hess Midstream to Sell From Neutral, Adjusts PT to $32 From $36Hess Midstream LP (HESM) has an average rating of Hold and mean price target of $38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$HESM
Research111d agoBarclays Downgrades Avis Budget to Underweight From Equal Weight, Raises Price Target to $150 From $95Avis Budget (CAR) has an average rating of Hold and mean price target of $114.29, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$CAR
Research111d agoBarclays Upgrades Celldex Therapeutics to Overweight From Underweight, Adjusts Price Target to $45 From $24Celldex Therapeutics (CLDX) has an average rating of buy and mean price target of $57, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$CLDX
Research111d agoMizuho Securities Initiates Coverage on Whirlpool With Neutral Rating, $55 Price TargetWhirlpool (WHR) has an average rating of Hold and mean price target of $66.22, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$WHR
Research111d agoTD Cowen Initiates Coverage on Voya Financial With Buy Rating, $100 Price TargetVoya Financial (VOYA) has an average rating of overweight and mean price target of $84.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$VOYA
Research111d agoSeaport Global Securities Initiates Coverage on Thor Industries With Neutral RatingThor Industries (THO) has an average rating of Hold and mean price target of $102.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$THO
Research111d agoUBS Initiates Healthcare Realty Trust at Neutral With $18 Price TargetHealthcare Realty Trust (HR) has an average rating of overweight and mean price target of $19.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$HR
Research111d agoUBS Initiates Healthpeak Properties at Neutral With $17 Price TargetHealthpeak Properties (DOC) has an average rating of overweight and mean price target of $19.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$DOC
Research111d agoGoldman Sachs Initiates Coverage on South Bow With Sell Rating, CA$40 Price Target$SOBO
Research111d agoBMO Capital Initiates Kyndryl at Market Perform With $15 Price TargetKyndryl (KD) has an average rating of hold and mean price target of $17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$KD
Research111d agoWilliam Blair Initiates Cameco at OutperformCameco (CCJ) has an average rating of overweight and mean price target of $129.56, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)$CCJ